NCT06761157Completed
Transrectal Evaluation After Discoid Resection for Endometriosis Intestinal
Source: ClinicalTrials.gov · Last updated 7 Jan 2025
Brief summary (registry, in English)
Evaluating the success of rectosigmoidoscopy performed after intestinal resection in women with deep endometriosis during surgery
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 19 (actual)
- First submitted
- 1 Dec 2024
- Start date
- 21 Mar 2022
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Endometriosis
- NCT number
- NCT06761157
What you commit to
- Study type: Observational
- Participants enrolled: 19
- From 21 Mar 2022 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are candidates for elective laparotomic surgery
- Patients with concomitant inflammatory bowel disease known in history (inflammatory bowel syndrome)
Who the study is looking for
- Women between the ages of 18 and 50 years
- Women with diagnosis made by instrumental examination such as transvaginal ultrasound, of deep endometriosis with suspected bowel involvement
- Women undergoing segmental or discoid resection for bowel endometriosis
- Obtaining informed consent
Age in the registry: 18 years to 50 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna Coordinator of this site? Confirm its status | Bologna | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.